Pharmaceuticals

Amarin Corp. (NASDAQ: AMRN) is the largest percentage gainer on any stock exchange on Monday, rising around 75% to $15.30. The company announced positive clinical data from its ANCHOR trial on its drug candidate AMR101, which is used to treat high triglycerides in patients. The Phase III trial met...

Hearing Tier 1 Firm Upgrades Amarin; Raises PT To $21 (NASDAQ: AMRN). This article may include mentions of rumors, chatter, or unconfirmed information. Readers should beware that while unconfirmed information may be correlated with increased volatility in securities, price movements based on...

Shares of ViroPharma Incorporated (NASDAQ: VPHM) are lower on the session by 9.67%, currently trading at $19.70. The stock has been moving largely higher over the past six months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying puts on the name...

By 10:25 am, the Dow Jones Industrial Average was down 207.75 points, or 1.68%, to 12,134.08, while the broader Standard & Poor's 500 index had dropped 20.56 points, or 1.56%. The NASDAQ composite index fell 49.97 points, or 1.81%. Some of the narrow based indexes that are supporting the...

Amarin Corporation PLC (NASDAQ: AMRN) shares moved up 79.29% to $15.72 at 10:15 am. The volume of AMRN shares traded was 4056% higher than normal. AMRN reported significant top-line results from its ANCHOR trial for its lead product candidate, AMR101. Titan Machinery Inc (NASDAQ: TITN) shares rose...

Titan Machinery Inc (NASDAQ: TITN) shares rose 13.10% to create a new 52-week high of $30.47. TITN reported upbeat Q4 earnings. Royal Gold Inc (NASDAQ: RGLD) shares reached $56.07 to create a new 52-week high, before falling to $56.88, representing a 3.92% gain. RGLD is scheduled to report its Q3...

Jefferies is out with its report today on Eli Lilly (NYSE: LLY), maintaining Hold. In a note to clients, Jefferies writes, "Q1 2011 results are better than consensus expectations due to a stronger top-line performance and better than expected operational margins. Non-GAAP 2011 EPS guidance has...

Amarin Corporation PLC (NASDAQ: AMRN) shares surged 79.06% to $15.70 at 9:45 am. AMRN reported significant top-line results from its ANCHOR trial for its lead product candidate, AMR101. Valley National Bancorp (NASDAQ: VLYWW) jumped 33.33% to $3.00. VLYWW's trailing-twelve-month operating margin...

Goldman Sachs has issued a report regarding the P3 Oral Scan study of tofacitinib from Pfizer (NYSE: PFE). According to the report, “ORAL Scan (full data expected at ACR in Nov) adds new information on the JAK joint benefit (crucial for establishing a competitive profile with the biologicals, such...

Johnson & Johnson (NYSE: JNJ) is in talks to potentially acquire Synthes for approximately $20 billion, after the Swiss medical device maker confirmed the talks. If J&J were able to acquire Synthes for around $20 billion, it would be a fairly cheap deal, as it would only be approximately a...

According to J.P. Morgan, Merck & Co (NYSE: MRK) and JNJ announced a settlement on the Remicade / Simponi arbitration on Friday. J.P. Morgan reported that under the revised terms of the agreement, MRK will relinquish rights for roughly 30% of the current franchise and will accelerate the move...

Pre-open movers US stock futures are lower this morning. Futures on the Dow Jones Industrial Average dipped 72 points to 12,231.00 and futures on the S&P 500 stock index fell 9.20 points to 1,309.80. Nasdaq 100 futures dropped 14 points to 2,295.75. A Peek Into Global Markets Negative...

According to J.P. Morgan, Johnson & Johnson (NYSE: JNJ) has for the last several months publicly discussed its interest in executing one or more large acquisitions. J.P. Morgan reported that this is why J&J is not buying back stock, despite pressure from shareholders and the fact that it's...

Eli Lilly & Co (NYSE: LLY) reported its Q1 adjusted EPS at $1.24, beating the consensus of $1.16. LLY reported its Q1 revenue at $5.84 billion, versus the consensus of $5.70 billion. LLY shares gained 0.73% to close at $36.01 on Friday. Read more from Benzinga's Company news.

US stock futures are lower this morning, as investors are awaiting earnings from Citigroup Inc (NYSE: C). Futures on the Dow Jones Industrial Average dipped 63 points to 12,240.00 and futures on the S&P 500 stock index fell 8.40 points to 1,310.60. Nasdaq 100 futures dropped 11 points to 2,298....